Fidelity® Select Biotechnology Portfolio (FBIOX)

Net Asset Value
1 Day
Overall Morningstar Rating
Style or Category
No Load
Sales Expenses
Expense Ratio
Morningstar Risk Rating™
Investment Objective The investment seeks capital appreciation. The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research- development- manufacture- and distribution of various biotechnological products- services- and processes and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position- as well as market and economic conditions to select investments. The fund is non-diversified.


1 month+6.22% 3 years+0.04%
3 months+4.89% 5 years+18.00%
1 year+23.00% Since inception+13.71%
Data through --

Peer Comparisonvs. Health

Performance 5-yr return+18.00%+14.29%
Expense ratio0.74%1.29%
Risk 5 year sharpe ratio0.650.90
Net assets$8.8B$3.0B
Average market cap$6.4B$9.5B
Average P/E--21.7
Portfolio turnover26%26%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyFidelity Investments
Fund manager & tenureRajiv Kaul / 12 Years
Minimal initial investment$2,500.00
Minimum IRA investment$2,500.00


U.S. stock92.87%
International stock4.09%
Fixed income0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
AMGN Amgen5.94%
ABBV AbbVie5.47%
BIIB Biogen4.17%
CELG Celgene3.77%
GILD Gilead Sciences3.03%
VRTX Vertex Pharmaceuticals Inc2.82%
ALXN Alexion Pharmaceuticals Inc2.40%
REGN Regeneron Pharmaceuticals2.10%
LOXO Loxo Oncology Inc2.04%
NBIX Neurocrine Biosciences Inc2.03%